Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?
Article in Neurology and Therapy (May 2023)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
How a Dosage Regimen Patent for RRMS Treatment May Satisfy the Written Description Requirement—A Lesson from Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc.
Article in Biotechnology Law Report (October 2022)
Usage of fingolimod combined with polyacetone system in the treatment of mouse kidney transplantation model
Article in Materials Express (January 2022)